Search results for "Hydroxymethyl"

showing 10 items of 313 documents

Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision

2008

OBJECTIVE: To assess whether the prescribing pattern of lipid-lowering drugs (LLD) changed after reimbursement criteria revision in a general practice in southern Italy. METHODS: From the Caserta-1 Local Health Service database, 93 general practitioners (GPs) who had consistently sent data about their patients during the years 2003-2005 were recruited. Prevalence of use and incidence of new treatments were calculated for each year, stratified by three drug cohorts: statins, omega-3 fatty acids, and fibrates. Subanalyses by gender, age, and indication of use were performed. RESULTS: Overall, 1-year prevalence of LLD use increased from 2003 to 2004. After reimbursement criteria revision (Nove…

Drug Utilizationmedicine.medical_specialtyPediatricsStatinSettore MED/09 - Medicina Internamedicine.drug_classMEDLINEstatinsInternal medicineFatty Acids Omega-3EpidemiologyHumansMedicinePharmacology (medical)RosuvastatinLipid-lowering drug Statins Omega-3 fatty acids Prevalence of use General practiceClofibrateReimbursementUnsaturated fatty acidHypolipidemic AgentsPharmacologygeneral practiceprevalence of usePrimary Health Careomega-3 fatty acidsbusiness.industryIncidence (epidemiology)General Medicinelipid-lowering drugSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheDrug UtilizationItalyInsurance Health ReimbursementSettore BIO/14 - FarmacologiaHydroxymethylglutaryl-CoA Reductase Inhibitorslipid-lowering drug; statins; omega-3 fatty acids; prevalence of use; general practicebusinessmedicine.drug
researchProduct

Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain.

2019

Abstract Background Drug treatment for secondary prevention of cardiovascular disease is recommended by guidelines, but it is not always followed in real life. This study wanted to assess the size of this gap and its impact on mortality in subjects after a cardiovascular event (MACE). Methods Patients with any of MACE in the period from January 1st 2011 to December 31st 2013, and more than one year of follow-up were selected from population of the Valencian Community. Drugs for secondary prevention were antiplatelets, renin-angiotensin system blockers and statins. Assessment of treatment was performed one year after the initial event. Mortality risk was assessed using Cox by the number of d…

DrugMalemedicine.medical_specialtyMedication Therapy Managementmedia_common.quotation_subjectmedicine.medical_treatmentPopulationMyocardial InfarctionAngiotensin-Converting Enzyme InhibitorsDisease030204 cardiovascular system & hematologyRevascularizationRisk Assessment03 medical and health sciencesAngiotensin Receptor Antagonists0302 clinical medicineInternal medicinemedicineSecondary PreventionHumans030212 general & internal medicineMyocardial infarctioneducationStrokemedia_commonAgededucation.field_of_studybusiness.industryConfoundingmedicine.diseaseSurvival AnalysisProfessional Practice GapsStrokeSpainFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessMacePlatelet Aggregation InhibitorsInternational journal of cardiology
researchProduct

An overview of statin-induced myopathy and perspectives for the future

2020

Introduction: Statins remain the most commonly prescribed lipid-lowering drug class for the treatment of atherosclerotic cardiovascular disease. Their well-recognized side effects are known as statin-associated muscle symptom (SAMS). Some advances in this field have been made in recent years, but the understanding of the mechanisms has lagged. Investigating the specific role of the anti-HMGCR autoantibody, pharmacokinetic genetic variants, characterization of the known phenotypes of statin toxicity, in relation to clinical markers of disease, is of high importance. Areas covered: We summarized currently available findings (on PubMed) related to SAMS and discussed the therapeutic approaches,…

DrugStatinUbiquinonemedicine.drug_classmedia_common.quotation_subjectHyperlipidemiasDiseasetherapeutic approaches030204 cardiovascular system & hematologyBioinformaticsPharmacogenomic Variants03 medical and health sciences0302 clinical medicineMuscular DiseasesRisk FactorsmedicineAnimalsHumansDrug InteractionsPharmacology (medical)Adverse effectHypolipidemic Agentsmedia_commondrug interactionbusiness.industryGeneral MedicineAtherosclerosisStatin induced myopathystatin-induced myopathyunderlying mechanismDrug classrisk factor030220 oncology & carcinogenesisCoenzyme Q10Hydroxymethylglutaryl-CoA Reductase Inhibitorsmyositis autoantibodieRisk assessmentbusinessstatin-associated muscle symptom
researchProduct

Adverse drug reaction and organ damage: the liver

2016

Drug-induced liver injury (DILI) is among the most challenging acute or chronic liver conditions to be handled by physicians. Despite its low incidence in the general population, DILI is a frequent cause of acute liver failure. As such, the possibility of DILI should be considered in all patients who present with acute liver damage, independent of any known pre-existing liver disease. DILI can be classified as intrinsic/dose-dependent (e.g., acetaminophen toxicity) or idiosyncratic/dose-independent, with the latter form being relatively uncommon. Amoxicillin-clavulanate is the antimicrobial that is most frequently associated with idiosyncratic DILI. Large, ongoing, prospective studies in we…

Drugmedicine.medical_specialtySettore MED/09 - Medicina InternaClinical presentationEpidemiologymedia_common.quotation_subjectPopulation03 medical and health sciencesLiver disease0302 clinical medicineRisk FactorsEpidemiologyInternal MedicinemedicineHumansRisk factorIntensive care medicineeducationmedia_commonLiver injuryeducation.field_of_studybusiness.industryIncidenceAnti-Inflammatory Agents Non-SteroidalBiomarkers; Clinical presentation; Diagnosis; Drug induced liver injury; Epidemiology; Risk factorBiomarkermedicine.diseaseDrug development030220 oncology & carcinogenesisDietary Supplements030211 gastroenterology & hepatologyPlant PreparationsDrug induced liver injuryRisk factorChemical and Drug Induced Liver InjuryHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessPharmacogeneticsDiagnosi
researchProduct

LDL and HDL subfractions, dysfunctional HDL: treatment options.

2014

Low-density lipoproteins (LDL) are considered as important risk factors for cardiovascular diseases (CVD), while highdensity lipoproteins (HDL) are well recognized for their putative role in reverse cholesterol transport and other atheroprotective functions. Both LDL and HDL are heterogeneous in nature, including various subfractions depending on the method of isolation (≥ 7 LDL and 10 HDL subspecies, respectively). While it is established that small, dense LDL (sdLDL) have atherogenic potential, the role of different HDL subfractions is still largely unclear. The majority of clinical studies suggest an atheroprotective role of larger HDL particles, although recent work has highlighted the…

Drugmedicine.medical_specialtymedia_common.quotation_subjectDysfunctional familychemistry.chemical_compoundRisk FactorsInternal medicineDrug DiscoveryCholesterylester transfer proteinmedicineHumansmedia_commonPharmacologybiologybusiness.industryCholesterolReverse cholesterol transportnutritional and metabolic diseasesLipoproteins LDLResidual riskEndocrinologychemistryCardiovascular Diseasesbiology.proteinlipids (amino acids peptides and proteins)Hdl subfractionsHydroxymethylglutaryl-CoA Reductase InhibitorsLipoproteins HDLbusinessNiacin
researchProduct

Partialsynthese neuer Ergolinderivate aus Clavinalkaloiden, 2. Mitt.1) O-Acyl-8-hydroxymethyl-6-methylergol-8-ene und -ergol-9-ene

1983

Die Titelverbindungen sind durch Acylierung von Elymoclavin (1) bzw. Lysergol (2) mit Saurechloriden, im Fall der Ester von 2 auch durch Isomerisierung von O-Acyl-1 mit aktiviertem Al2O3 darstellbar. Umgekehrt fuhrt die Acylierung von 2 in bestimmten Fallen spontan zur Bildung eines Gemisches der O-Acylderivate von 1 und 2.. Partial Synthesis of New Ergoline Derivatives from Clavine Alkaloids, II: O-Acyl-8-(hydroxymethyl)-6-methylergol-8-enes and -ergol9-enes The title compounds can be prepared by acylation of elymoclavine (1) and lysergole (2), respectively, with acid chlorides or, in the case of the esters of 2, by isomerization of O-acyl-1 with activated Al2,O3. On the other hand, in cer…

ElymoclavineClavine AlkaloidsPharmaceutical ScienceMedicinal chemistryErgolineAcylationchemistry.chemical_compoundchemistryLysergolDrug DiscoverymedicineHydroxymethylIsomerizationmedicine.drugArchiv der Pharmazie
researchProduct

PURIFICATION OF HARDWOOD-DERIVED AUTOHYDROLYSATES

2012

Carbohydrate-containing hydrolysates (1.1 to 14.9% of wood dry matter) obtained from autohydrolysis (at 130 to 150°C for 30 to 120 minutes) of birch (Betula pendula) chips prior to pulping were purified with respect to non-carbohydrate materials, without carbohydrate losses, either by ethyl acetate extraction or XAD-4 resin treatment. In the former case, about 50% of lignin and practically all the furanoic compounds (2-furaldehyde and 5-(hydroxymethyl)furfural) could be removed, whereas in the latter case, the corresponding amounts were about 30% and 50 to 90%, respectively. A partial recovery of various unsaturated impurities is of importance, because they may act as inhibitors when bioche…

Environmental EngineeringChromatographylcsh:BiotechnologyExtraction (chemistry)Ethyl acetateEthyl acetateBioengineeringFurfuralHydrolysatechemistry.chemical_compoundchemistryAutohydrolysisBiorefininglcsh:TP248.13-248.65HardwoodLigninOrganic chemistryDry matterHydroxymethylBiorefiningBiomassWaste Management and DisposalXAD-4PurificationBioResources
researchProduct

Multivariate Correlation between Analysis Data on Dissolved Organic Material from Scots Pine (Pinus sylvestris) Chips and their Autohydrolysis Pre-Tr…

2013

Various chemometric techniques were used to establish the relationship between the autohydrolysis conditions prior to pulping and the chemical compositions of the soluble organic materials removed from Scots pine (Pinus sylvestris) wood chips. The aqueous chip pre-treatments (autohydrolysis) were administered at 130 °C and 150 °C for 30, 60, 90, and 120 min, and the hydrolysates obtained were characterized in terms of total carbohydrates (various mono-, oligo-, and polysaccharides together with uronic acid side groups), volatile acids (acetic and formic acids), lignin, and furans (furfural and 5-(hydroxymethyl)furfural). Based on the analytical data gathered, a relatively accurate model for…

Environmental Engineeringlcsh:BiotechnologyCarbohydratesPrincipal component analysisligninBioengineeringUronic acidFurfuralHydrolysatechemistry.chemical_compoundlcsh:TP248.13-248.65volatile acidsLigninOrganic chemistryHydroxymethylBiorefiningFuransWaste Management and Disposalscots pineChromatographyAqueous solutionbiologyfungiScots pinebiology.organism_classificationAutohydrolysischemistrybiorefiningBioResources
researchProduct

Hypercholesterolemic patients have higher eryptosis and erythrocyte adhesion to human endothelium independently of statin therapy

2021

BACKGROUND Phosphatidylserine (PS) externalization out of the membrane facilitates the eryptotic erythrocytes (EE) binding to endothelial cells (EC), potentially leading to atherosclerosis. Thus, the levels of eryptosis and interactions of EE-EC in hypercholesterolemic patients, either non-medicated or medicated, compared with healthy subjects were studied. METHODS A total of 56 subjects clustered into three groups: (control (n = 20), hypercholesterolemic non-treated (HCNT) (n = 15), and statin-treated (HCT) (n = 21)) were enrolled in this cross-sectional study. Biochemical parameters were determined with validated and standard methods. PS exposure was estimated from annexin-V-binding, cell…

ErythrocytesApolipoprotein BEndotheliumEryptosisPharmacologymedicine.disease_causeMicrocirculationFlow cytometrychemistry.chemical_compoundmedicineHumansEndotheliumbiologymedicine.diagnostic_testbusiness.industryEndothelial CellsGeneral MedicineGlutathionePhosphatidylserineAdhesionCross-Sectional Studiesmedicine.anatomical_structurechemistrybiology.proteinCalciumHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessOxidative stressInternational Journal of Clinical Practice
researchProduct

Effect of simvastatin on desaturase activities in liver from lean and obese zucker rats

1993

The effect of simvastatin, a hypocholesterolemic drug, on the biosynthesis of arachidonic acid was studied in obese and lean Zucker rats. After administration of 2 mg/kg body weight/d for 13 d, delta 6 and delta 5 desaturase activities were measured in liver microsomes at two substrate concentrations. In untreated rats, the delta 6 desaturation rate was similar in the obese and lean rats when measured at saturating substrate levels, whereas delta 5 desaturation was lower in the obese animals. Treatment with simvastatin did not change delta 6 desaturation in either phenotype but increased delta 5 desaturation in obese rats to reach the unchanged rate observed in lean animals. The changes wer…

Fatty Acid DesaturasesMaleSimvastatinmedicine.medical_specialtyClinical chemistryIn Vitro TechniquesBiologyLinoleoyl-CoA DesaturaseBiochemistrychemistry.chemical_compoundDelta-5 Fatty Acid DesaturaseInternal medicinemedicineAnimalsLovastatinObesityPhospholipidschemistry.chemical_classificationAnticholesteremic AgentsFatty AcidsOrganic ChemistryMetabolic disordernutritional and metabolic diseasesFatty acidCell Biologymedicine.diseaseHydroxymethylglutaryl-CoA reductaseRatsRats ZuckerEndocrinologychemistrySimvastatinFatty Acids UnsaturatedMicrosomes LiverMicrosomeArachidonic acidLipidologymedicine.drugLipids
researchProduct